title: Intravitreous injections.
authors.forename: Guy
authors.initials: G
authors.lastname: Bylsma
authors.forename: Robyn
authors.initials: R
authors.lastname: Guymer
authors.forename: Salmaan
authors.initials: S
authors.lastname: Qureshi
authors.forename: Trevor
authors.initials: T
authors.lastname: Gin
authors.forename: Penny
authors.initials: P
authors.lastname: Allen
authors.forename: Pradheep
authors.initials: P
authors.lastname: Madhok
authors.forename: Mark
authors.initials: M
authors.lastname: McCombe
authors.forename: Alex
authors.initials: A
authors.lastname: Harper
mesh_terms: D000818:Animals; D052157:Aptamers, Nucleotide / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007267:Injections / Q000379:methods*; D017410:Practice Guidelines as Topic; D014822:Vitreous Body / Q000187:drug effects*
chemical_list: D052157:Aptamers, Nucleotide; C495058:pegaptanib